Neos Therapeutics (NEOS) Reports In-Line Q2 EPS

Neos Therapeutics (NASDAQ: NEOS) reported Q2 EPS of ($0.83), in-line with the analyst estimate of ($0.83). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $5.67 million.

For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.

You May Also Be Interested In

• Fiserv (FI) Tops Q1 EPS by 9c; Boosts outlook
• JetBlue Airways (JBLU) stock dips as revenue declines
• UPS Q1 earnings top consensus expectations despite revenue dip